All is Well with NatureWell
ANOTHER Massive Revenue Explosion!Would you invest in a company with monthly year over year 2007 revenues (01/2007 - 01/2007) rising at an average rate of nearly 1000% over the same period in 2006?
That is exactly what is taking place at NatureWell, Inc. (OTCBB: NAWL).
Revenues up over 600%
NAWL ended the trading week with this: NatureWell's May 2007 Revenues Up 625%. I think we are in for another hyperactive NAWL trading day on Monday. (*See Stock Chart further below)
For the eleven months ended May 31, 2007, NatureWell's revenue jumped in excess of 400% over the same period in 2006! Now, I am no accountant, but with high triple digit sales increases like these, it won't take long for other market participants to join the party.
Five Months and Counting
The real beauty here has been consistency. We are not talking a month or two of large revenue increases, but is FIVE big months (nearly half the year) . . . and counting!
- January 2007 over January 2006 + 428%
- February 2007 over February 2006 + 1785%
- March '07 over March '06 + 1077%
- April '07 over April '06 + 954%
- May '07 over May '06 + 625%
And . . . if NatureWell can sustain this kind of growth into 2008 . . . imagine how exciting the exponential growth effect will be.
NatureWell's Chairman and CEO, James Arabia had this to say: "May was another good month for us. Right now, we pretty well know how many new practitioner accounts and how much revenue can be generated on a monthly basis by each sales representative once they have been properly trained and begin making calls. And the numbers so far make a lot of sense. So for now, the priority is on expanding our sales and customer service representatives with the hope of opening new practitioner accounts at the same rate per sales representative that our experience demonstrates."
Migraine Prevention
If these 2007 monthly growth figures aren't enough to pique your interest, NAWL is gaining a solid foothold in the multi-billion dollar migraine treatment/prevention market. With the treatment of migraines in United States alone at approximately $2.5 billion annually and according to the National Headache Foundation an estimated 28.5 million Americans are affected by migraines, NAWL has barely scratched at the potential market share it plans to obtain.
Of course the big pharmaceutical companies have there own costly and potential harmful, side effect laden (we've all heard the drug company disclaimer on television, heck they take up half the darn commercials) drugs for the treatment of migraines, but that is no competition for NAWL. NatureWell's 100% natural MigraSpray does not only treat migraines, IT PREVENTS THEM. With the U.S. market for the prevention of migraine virtually untapped, there may be as much as $3.0 to $4.0 billion annually waiting for MigraSpray once it hits the mainstream.
With as many as 40 million Americans suffering from migraines, many of them without health insurance, I'd say NatureWell's moderately priced, over the counter solution sits in a unique and enviable position.
Whats All The Buzz About? - This May Help . . .
MigraSpray® is a patented homeopathic remedy formulation that contains the active natural ingredient Feverfew. The product is being positioned as a comprehensive first-line of defense for treating migraine headaches. The medication, a sublingual spray (sprayed under the tongue) - can be used for acute migraine attacks, as well as for prevention of migraine headaches. If a migraine attack still occurs while MigraSpray is being used preventatively, the medication may also be used to treat the acute attack. This comprehensive approach is highly effective in dramatically reducing or eliminating migraines and represents a safe alternative to expensive prescription medications, which have potentially serious side effects.
In Summary
NAWL has positioned itself as the only, 'over- the-counter', 'all natural' migraine product currently marketed exclusively to healthcare practitioners such as chiropractors, CAM MDs, Osteopaths, Naturopaths, Physicians (GP), and Acupuncturists. NAWL estimates that the potential, untapped market for these healthcare professionals is approximately 217,500 and with more and more Americans fearing the side effects of drugs offered by the likes of Merck and Pfiser, this number is growing at record rates.
This targeted customer base is not aware, nor being offered products similar to NatureWell's MigraSpray. This creates a unique opportunity for initial sales agreements and product demonstrations. NAWL is quickly entrenching itself within this growing population of healthcare practitioners, and therefore creating a significant barrier for potential competitors.
If history repeats itself, Monday should prove to be another hyperactive trading day for NatureWell Inc. One of these times it is going to take off, and not look back. And with revenue increases like these, it looks like that day is drawing nearer and nearer. Best do your homework, and not be caught sitting on the sidelines when that day arrives.
Labels: Naturewell, Naturewell Inc., NAWL
0 Comments:
Post a Comment
<< Home